Generic EGFR Inhibitor for NSCLC

So, Mobocertinib is a kind of medicine that blocks this thing called the Epidermal Growth Factor Receptor (EGFR). It’s made for folks with a specific kind of lung cancer—non-small cell lung cancer (NSCLC)—and they have this mutation in a part of the EGFR called exon 20. It works by locking onto the EGFR, which is a key player in cancer cells, and it slows down the growth of tumors.

You can get this stuff in capsules, each one a 40 mg kick. Doctors usually tell adults to take 160 mg of this stuff every day. You can take it with or without food—it’s up to you.

Each bottle comes with 90 capsules for you to pop.